CLINICAL ROLE -
NCCN Announces Expanded Practice Guidelines for Breast Cancer With Hereditary Risks
The guidelines were expanded to include the growing use of genetic testing within cancer prevention, screening, and treatment.
Read More
Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome
Familial chylomicronemia syndrome (FCS) currently has no FDA-approved treatment and is associated with an increased risk of acute pancreatitis.
FDA Grants Orphan Drug Designation to RAG-21 for Treatment of ALS
If approved, RAG-21 can offer improved outcomes in patients with amyotrophic lateral sclerosis (ALS), particularly those with aggressive subtypes.
Women With Natural Menopause at a Later Age May Have an Increased Risk of Asthma
Women aged 40 to 44 years at the time of natural menopause showed about a 30% decreased risk for asthma incidence.
Implementing CDC’s Core Elements of Sepsis
The agency outlines key elements for building effective hospital sepsis programs.
FDA Grants Rare Pediatric Disease, Fast Track Designations to Gildeuretinol for Stargardt Disease Treatment
As a rare and serious pediatric disorder, Stargardt disease can cause vision complications in patients.
Fall 2024 Quiz: Test Your Pharmacy Knowledge!
This quiz was created in collaboration with PTCE™.
Vaccination Conversations: Mastering Patient Q&A at the Pharmacy
When you’re unsure about answering a patient question, err on the side of caution and refer them to a pharmacist.
Rusfertide Reduces Phlebotomy Need, Improves Symptom Control in Polycythemia Vera
Rusfertide may sustain hematocrit levels in patients with polycythemia vera.
Usage of AI With PET/CT Images Could Detect Impacts of Immunotherapy in Lung Cancer
The risk of developing interstitial lung disease after immunotherapy was 6.5 times higher in individuals with high inflammation.
FDA Accepts sNDA for Darolutamide With ADT for Patients With mHSPC
The supplemental new drug application (sNDA) is based on results from a phase 3 trial that enrolled patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events
There were 2 main types of switches, including switching to rituximab subcutaneous and switching among different intravenous rituximab treatments.
Novel IVIG Formulation KIG10 Is Effective, Well Tolerated in Adults With Primary Immunodeficiency
No acute serious bacterial infections were observed in a trial of patients with the debilitating immune disorder, a strong mark of safety and tolerability.
Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation
ALE.P02 could provide further treatment options for advanced or metastatic anti–claudin-1+ squamous cancers.
Intravenous Injections of Zanidatamab-Hrii Receives FDA Accelerated Approval for IHC+ BTC
The indication is for adults with previously treated unresectable or metastatic HER2+ (IHC+) biliary tract cancer (BTC) as detected by an FDA-approved test.
Higher Composite Dietary Antioxidant Index Reduces Risk of Diabetes for Women
Investigators also established a negative association with higher vitamin C intake and diabetes prevalence.
Kisunla From Eli Lilly
Advancing Compounding Standards: Insights From the USP Compounding Implementation Workshop
The workshop addressed trends, initiatives, and regulations for quality compounding.
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
In this episode of Public Health Matters, Christina Madison discusses pharmacist-physician collaborations with Amina Abubakar and Stephen Lewis.
Listen
Pharmacy Students Using TikTok to Take Learning to the Next Level
Through an assignment to create a TikTok infomercial, students master new concepts and have positive educational experiences via social media.
Increase of Vitamin D Supplements Could Lower Blood Pressure Among Older Individuals With Obesity
Vitamin D and calcium decreased systolic and diastolic blood pressure among older individuals with obesity.
Investigators Present New Data About HPV Vaccine, Supporting Its Use
Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.
Nasal Swab Test Can Predict COVID-19 Severity Through Autoantibody Analysis
Severity of a COVID-19 illness could be determined by examining autoantibodies in the nasal cavity, allowing more personalized treatment protocols.
Early Asthma Onset Associated With Memory and Executive Function Difficulties in Children
Inflammation associated with asthma in children could perturb neurodevelopment.
Study Finds Nearly 75% of Adults 25 and Older Have Overweight or Obesity
If patterns and trends were to continue, the authors predict that nationwide overweight and obesity prevalence in adults will surpass 80% by 2050.
Payment Disrupters and Opportunities: Key Trends That Impacted Pharmacy in 2024
PBM reforms and regulatory changes have reshaped the industry landscape.
Alzheimer Disease Treatment Can Improve Population Health and Health Equity
Policies that focus on earlier diagnosis, treatment initiation, and expanded access to treatment can further improve treatment and health equity impacts.
Condition Watch: Respiratory Syncytial Virus
Updates in the Treatment of Moderate to Severe Atopic Dermatitis: A Focus on JAK Inhibitors
Treatment often involves a combination of preventive measures, topical therapies, and systemic treatments.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa
Bimekizumab-bkzx is the first and only approved medication that targets both interleukin (IL) 17F and IL-17A.